Publications by authors named "Maura Danni"

Claim this Profile
E
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.
Pietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, Francesco Patti, Eleonora Cocco, Maura Chiara Danni

J Neurol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY).
Clara G Chisari, Assunta Bianco, Vincenzo Brescia Morra, Massimiliano Calabrese, Fioravante Capone, Maura Danni

Neurotherapeutics· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab.
Alessandra Sottini, Virginia Quaresima, Mosè Barbaro, Lucia Moiola, Massimo Filippi, Maura Chiara Danni

J Neuroimmunol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Dimethylfumarate on Sleep in Multiple Sclerosis Patients: An Actigraphic Study.
Chiara Rocchi, Lucrezia Lombardi, Serena Broggi, Maura Chiara Danni, Simona Lattanzi

CNS Neurol Disord Drug Targets· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential prognostic value of circulating inflamma-miR-146a-5p and miR-125a-5p in relapsing-remitting multiple sclerosis.
Angelica Giuliani, Simona Lattanzi, Deborah Ramini, Laura Graciotti, Maura Chiara Danni

Mult Scler Relat Disord· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome in multiple sclerosis patients treated with fingolimod.
Simona Lattanzi, Chiara Rocchi, Maura Danni, Ruja Taffi, Raffaella Cerqua

Mult Scler Relat Disord· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep in multiple sclerosis patients treated with interferon beta: an actigraphic study.
Chiara Rocchi, Alessandra Pulcini, Cristina Vesprini, Viviana Totaro, Giovanna Viticchi, Maura Chiara Danni

Neurol Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral hemodynamics in patients with multiple sclerosis.
Simona Lattanzi, Maria Cristina Acciarri, Maura Danni, Ruja Taffi, Raffaella Cerqua

Mult Scler Relat Disord· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study.
Clara Grazia Chisari, Claudio Solaro, Pasquale Annunziata, Roberto Bergamaschi, Assunta Bianco, Maura Chiara Danni

J Neurol Neurosurg Psychiatry· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parvovirus B19 infection in a patient with multiple sclerosis treated with ocrelizumab.
Simona Lattanzi, Giulia Carlini, Maria Cristina Acciarri, Maura Danni, Mauro Silvestrini

Acta Neurol Belg· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.
Alessandra Solari, Ambra Mara Giovannetti, Andrea Giordano, Carla Tortorella, Valentina Torri Clerici, Maura Chiara Danni

Front Neurol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palatability and oral cavity tolerability of THC:CBD oromucosal spray and possible improvement measures in multiple sclerosis patients with resistant spasticity: a pilot study.
Giacomo Lus, Roberto Cantello, Maura Chiara Danni, Agusto Rini, Paola Sarchielli

Neurodegener Dis Manag· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence to oral disease-modifying therapies in multiple sclerosis patients.
Simona Lattanzi, Maura Danni, Ruja Taffi, Raffaella Cerqua, Giulia Carlini

J Neurol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).
Silvia Messina, Claudio Solaro, Isabella Righini, Roberto Bergamaschi, Simona Bonavita, Maura Chiara Danni

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysis.
Simona Lattanzi, Claudia Cagnetti, Maura Danni, Leandro Provinciali, Mauro Silvestrini

J Neurol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of disability progression in fingolimod-treated patients.
Simona Lattanzi, Maura Danni, Raffaella Cerqua, Ruja Taffi, Leandro Provinciali

J Neurol Sci· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A RCT Comparing Specific Intensive Cognitive Training to Aspecific Psychological Intervention in RRMS: The SMICT Study.
Flavia Mattioli, Chiara Stampatori, Fabio Bellomi, Maura Danni, Laura Compagnucci

Front Neurol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores.
Sara Zagaglia, Simona Balestrini, Eva Perticaroli, Maura C Danni, Simona Luzzi

Neurol Sci· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis